JESÚS MARÍA
OJANGUREN BERGAZ
Ikertzailea 2022-(e)ra arte
Hospital Clinic Barcelona
Barcelona, EspañaHospital Clinic Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2007
-
Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated with adverse prognosis
Leukemia, Vol. 21, Núm. 1, pp. 143-150
2004
-
Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities
American Journal of Surgical Pathology, Vol. 28, Núm. 6, pp. 736-747